POS1336 RETROPERITONEAL FIBROSIS IN ERDHEIM-CHESTER DISEASE HAS UNIQUE PRESENTING AND PROGNOSTIC FEATURES: A SINGLE CENTRE RETROSPECTIVE COMPARATIVE COHORT STUDY

Volume: 80, Issue: Suppl 1, Pages: 950 - 951
Published: May 19, 2021
Abstract
Background: Erdheim-Chester disease (ECD) is a multisystemic non-Langerhans cell histiocytosis. Retroperitoneal fibrosis (RPF) is a common ECD feature, found in up to 60% of patients. Besides ECD, RPF differential diagnosis includes other clinical entities of rheumatological interest, such as idiopathic RPF and IgG4-related disease (IgG4-RD). Since ECD management does not include glucocorticoids and mainly relies on the use of anti-neoplastic...
Paper Details
Title
POS1336 RETROPERITONEAL FIBROSIS IN ERDHEIM-CHESTER DISEASE HAS UNIQUE PRESENTING AND PROGNOSTIC FEATURES: A SINGLE CENTRE RETROSPECTIVE COMPARATIVE COHORT STUDY
Published Date
May 19, 2021
Volume
80
Issue
Suppl 1
Pages
950 - 951
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.